State of the art of Smo antagonists for cancer therapy: Advances in the target receptor and new ligand structures

dc.catalogadorasg
dc.contributor.authorEspinosa-Bustos, C.
dc.contributor.authorMella, J.
dc.contributor.authorSoto-Delgado, J.
dc.contributor.authorSalas Sanchez, Cristian Osvaldo
dc.date.accessioned2024-03-04T15:12:32Z
dc.date.available2024-03-04T15:12:32Z
dc.date.issued2019
dc.fechaingreso.objetodigital2025-11-02
dc.fuente.origenORCID
dc.identifier.doi10.4155/fmc-2018-0497
dc.identifier.urihttps://doi.org/10.4155/fmc-2018-0497
dc.identifier.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-85064121690&partnerID=MN8TOARS
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/81609
dc.information.autorucEscuela de Química; Salas Sanchez, Cristian Osvaldo; 0000-0001-7620-2459; 101425
dc.issue.numero6
dc.language.isoen
dc.nota.accesocontenido parcial
dc.pagina.final638
dc.pagina.inicio617
dc.revistaFuture Medicinal Chemistry
dc.rightsacceso restringido
dc.titleState of the art of Smo antagonists for cancer therapy: Advances in the target receptor and new ligand structures
dc.typeartículo
dc.volumen11
sipa.codpersvinculados101425
sipa.trazabilidadORCID;2024-01-22
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
State of the Art of Smo Antagonists for Cancer Therapy- Advances in the Target Receptor and New Ligand Structures.pdf
Size:
185.56 KB
Format:
Adobe Portable Document Format
Description: